Clinical Trials Browser

Phase 3 × Arthritis, Rheumatoid × tofacitinib × Clear all

NCT00960440 2018-12-19

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Phase 3 Completed

399 enrolled 51 charts

Arthritis, Rheumatoid